Agenus (AGEN) Other Non-Current Liabilities (2010 - 2026)
Agenus' (AGEN) quarterly Other Non-Current Liabilities came in at $247000.0 in Q1 2026, down 67.54% year-on-year from $761000.0 in Q1 2025, and down 4.63% quarter-over-quarter from $259000.0 in Q4 2025.
Agenus (AGEN) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Agenus' Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $247000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 67.54% year-over-year to $247000.0 in Q1 2026; TTM through Mar 2026 was $247000.0, a 67.54% decrease from a year earlier, with the FY2025 full-year figure at $259000.0, down 64.91% from the prior year.
- Other Non-Current Liabilities slipped to $247000.0 in Q1 2026 per AGEN's latest filing, from $259000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $14.7 million in Q4 2022 and bottomed at $247000.0 in Q1 2026.
- The 5-year median for Other Non-Current Liabilities is $1.5 million (2022), against an average of $3.9 million.
- Across the five-year window, Other Non-Current Liabilities soared 871.44% in 2023 and sank 90.65% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $14.7 million in 2022, then tumbled by 63.13% to $5.4 million in 2023, then slumped by 86.38% to $738000.0 in 2024, then tumbled by 64.91% to $259000.0 in 2025, then declined by 4.63% to $247000.0 in 2026.
- Per Business Quant, the three latest AGEN Other Non-Current Liabilities figures stand at $247000.0 (Q1 2026), $259000.0 (Q4 2025), and $376000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 247,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Sep 30, 2025 | 376,000.00 |
| Jun 30, 2025 | 752,000.00 |
| Mar 31, 2025 | 761,000.00 |
| Dec 31, 2024 | 738,000.00 |
| Sep 30, 2024 | 777,000.00 |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Jun 30, 2023 | 11.08 Mn |
| Mar 31, 2023 | 13.91 Mn |
| Dec 31, 2022 | 14.70 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Sep 30, 2021 | 3.74 Mn |
| Jun 30, 2021 | 4.13 Mn |